Ain Shams university
Cairo, Egypt, 11111
NCT Number: NCT06847412
This study evaluates and compares the effectiveness of two distinct ventilation strategies-escalating PEEP and lung recruitment maneuvers-in improving oxygenation (i.e., managing hypoxemia) in COPD patients undergoing VATS.
This study is active but is not currently recruiting participants.
Notify Me20 year–60 year
All sexes
Interventional
Not applicable
Cairo, Egypt, 11111
A) Preoperative settings :
B) Intraoperative settings:
Electrocardiogram (ECG), non-invasive blood pressure (NIBP), pulse oximeter (SpO2) will be applied, and baseline readings will be taken before induction.
Anaesthesia will be induced after a period of preoxygenation with 100% oxygen for 2-3 minutes with intravenous injection of fentanyl 2 µg/kg, propofol 2 mg/kg and a muscle relaxant (Atracurium) 0.5 mg/kg after loss of patient consciousness. Lung isolation is achieved using a double-lumen endotracheal tube, Fiberoptic bronchoscopy is typically used to guide and confirm the placement and positioning of the tube 11.
Patients often requires the placement of invasive monitoring devices, such as invasive blood pressure (IBP) lines and central venous lines (CVL).
Anaesthesia will be maintained by 1-2 % of isoflurane in 50% oxygen/air mixture according to oxygen state and 0.1 mg/kg atracurium, ventilation parameters that maintain normocapnia (CO2 between 35- 40 mmHg). Fluids as crystalloids used by a fluid chart for the deficit and maintenance as needed.
The surgery typically begins with the patient positioned in a full lateral decubitus posture tailored to the side of the operation or in a supine position with appropriate support to access the chest.
Ventilatory setting:
Typically, an initial PEEP of 5 cm H₂O is used in all patients,
Group A:
PEEP is typically increased in 2-3 cm H₂O increments while monitoring the patient's response (oxygenation, hemodynamics, and lung compliance).
Group B:
A sustained inflation:
Set the ventilator to CPAP mode and increase the pressure to 30 cm H2O for 30 s.
C) Postoperative settings:
Follow up patients in recovery room whether transferred to ICU or to Ward, data will be recorded at the following times 1 h, 2 h, 6 h, 12 h, and 24 h. Both groups will be compared to each other according to the following variables:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Typically, an initial PEEP of 5 cm H₂O, then PEEP is increased in 2-3 cm H₂O increments while monitoring the patient's response (oxygenation, hemodynamics, and lung compliance).
Set the ventilator to CPAP mode and increase the pressure to 30 cm H2O for 30 s.
Time frame: 6 months
The incidence of post-operative patients requiring ICU admission
Time frame: 6 months
Intraoperative Hemodynamic instability, hypoxemia & Hypercapnia Post operative Needs of mechanical ventilation. Post operative pulmonary complications.
Ain Shams University
Other
Comparative Study of Escalating PEEP (Positive End Expiratory Pressure) vs. Lung Recruitment by Sustained Inflation Strategies for Managing Hypoxemia in COPD Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05556187
COPD, Chronic Disease
Hvidovre, Denmark
View Trial DetailsNCT01377051
Arrhythmias, Cardiac, COPD
Milan, Italy
View Trial DetailsNCT07512687
Chronic Disease, Chronic Obstructive Pulmonary Disease
Buffalo, New York, United States
View Trial DetailsNCT07451977
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD)
Lumezzane, Brescia, Italy
View Trial Details